CXCR6

Chr 3

C-X-C motif chemokine receptor 6

Also known as: BONZO, CD186, CDw186, STRL33, TYMSTR

The protein is a G protein-coupled receptor that serves as the exclusive receptor for chemokine CXCL16 and regulates T lymphocyte migration to peripheral tissues including liver, spleen, intestine, lungs, and skin. Mutations cause autosomal recessive combined immunodeficiency characterized by recurrent infections and impaired T cell responses. The gene primarily affects the immune system through disruption of T lymphocyte trafficking and positioning in lymphoid and non-lymphoid tissues.

OMIMResearchSummary from RefSeq, UniProt
MultiplemechanismLOEUF 1.55
Clinical SummaryCXCR6
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
8 unique Pathogenic / Likely Pathogenic· 31 VUS of 47 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.55LOEUF
pLI 0.000
Z-score 0.42
OE 0.84 (0.481.55)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
1.28Z-score
OE missense 0.73 (0.630.84)
130 obs / 178.0 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.84 (0.481.55)
00.351.4
Missense OE0.73 (0.630.84)
00.61.4
Synonymous OE1.11
01.21.6
LoF obs/exp: 7 / 8.3Missense obs/exp: 130 / 178.0Syn Z: -0.76
DN
0.79top 25%
GOF
0.78top 25%
LOF
0.1994th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

47 submitted variants in ClinVar

Classification Summary

Pathogenic7
Likely Pathogenic1
VUS31
Likely Benign4
Benign1
7
Pathogenic
1
Likely Pathogenic
31
VUS
4
Likely Benign
1
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
7
0
7
Likely Pathogenic
0
0
1
0
1
VUS
0
28
3
0
31
Likely Benign
0
1
1
2
4
Benign
0
0
0
1
1
Total02912344

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

CXCR6 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →